Results 191 to 200 of about 30,272 (291)

Tunable CAR-NK-92 activity in the tumor microenvironment via a dual ATF4-responsive circuit. [PDF]

Front Immunol
Manchon E, Hirt N, Soundiramourty A, Versier B, Christen Y, Charron D, Mallet J, Jabrane-Ferrat N, Serguera C, Al-Daccak R.   +9 more
europepmc   +1 more source

CAR-NK technology in the treatment of glioblastoma

Central European Journal of Immunology, 2023
Zarychta, Julia, Kowalczyk, Adrian
openaire   +1 more source

Roadblocks, Relationality and Resilient Resistance in Post‐coup Myanmar

Development and Change, EarlyView.
ABSTRACT Following Myanmar's military coup in February 2021, the State Administrative Council (SAC) established checkpoints between towns under its control and rural areas increasingly governed by anti‐junta resistance forces. Here, military personnel command trade and extort from people, inflating the price of consumer goods and agricultural inputs ...
Gerard McCarthy, Kyle Nyana
wiley   +1 more source

Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population‐Based Study

European Journal of Haematology, EarlyView.
ABSTRACT Adult hemophagocytic lymphohistiocytosis (HLH) is a rare, life‐threatening syndrome triggered by various conditions. A nationwide study of the incidence and outcomes of HLH in Denmark over 23 years (2000–2023) was performed. Adults (≥ 18 years) with HLH and triggering diseases were identified in the Danish National Patient Registry and/or the ...
Mads Okkels Birk Lorenzen, Martin Jensen, Rasmus Rask Kragh Jørgensen, Paw Jensen, Henrik Frederiksen, Dennis L. Hansen, Daniel El Fassi, Morten Nørgaard Andersen, Tarec Christoffer El‐Galaly   +8 more
wiley   +1 more source

Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy. [PDF]

Front Pharmacol
Cianga VA, Antohe I, Minciună C, Dăscălescu A.   +3 more
europepmc   +1 more source

Development of Chimeric Antigen Receptor‐Modified NK Cells for the Immunotherapy of Adult T‐Cell Leukemia/Lymphoma

European Journal of Haematology, EarlyView.
ABSTRACT Adult T‐cell leukemia/lymphoma (ATL) is an aggressive hematological malignancy with a poor prognosis and limited therapeutic options. ATL cells exhibit aberrant surface glycosylation patterns resulting from dysregulated glycosyltransferase expression, representing a potentially tumor‐specific therapeutic target.
Yuichiro Uchida, Seigo Tateo, Masahiro Wakao, Hiroyuki Shinchi, Hayate Sawayama, Akira Fukumoto, Makoto Yoshimitsu, Yasuo Suda   +7 more
wiley   +1 more source

Programmable iPSC-derived CAR-NK vesicles remodel the immune microenvironment and eradicate tumors. [PDF]

Cell Rep Med
Zhang H, Li S, Liu C, Gongye X, Li H, Ji Y, Ju CW, Jia W, Niu X, Guan Y, Zhai X, Jin B, Xia P.   +12 more
europepmc   +1 more source

From Time‐Limited Therapy to Treatment‐Free Observation: The Evolving Role of MRD in CLL Management

European Journal of Haematology, EarlyView.
ABSTRACT The integration of measurable residual disease (MRD) into the management of chronic lymphocytic leukemia (CLL) has emerged as a major advance in risk stratification and trial design, particularly in the context of time‐limited, targeted regimens.
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Maria Eugenia Alvaro, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Mamdouh Skafi, Valter Gattei, Fortunato Morabito, Massimo Gentile   +13 more
wiley   +1 more source

The Decentralization of Liquor Policies in Texas During the Post‐Prohibition Era

International Economic Review, EarlyView.
ABSTRACT We examine the decentralization of liquor policies in Texas during the Post‐Prohibition era using newly collected historical legislative roll call data. By combining these data with local referendum vote shares, we analyze both legislators' and constituents' preferences on liquor policy.
Andrew Arnold, Holger Sieg
wiley   +1 more source

Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid Tumors. [PDF]

Cells
Chung JY, Kim JE, Cha D, Lee HJ, Verhoeyen E, An HJ, Park JE.   +6 more
europepmc   +1 more source